| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6108397 | Journal of Hepatology | 2008 | 7 Pages |
Abstract
Hepatic steatosis and elevated ALT levels are risk factors for progression of fibrosis in chronic hepatitis C patients who fail to achieve a SVR to IFN therapy and therefore may be therapeutic targets to halt the potentially progressive disease.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Masayuki Kurosaki, Kotaro Matsunaga, Itsuko Hirayama, Tomohiro Tanaka, Mitsuaki Sato, Nobutoshi Komatsu, Naoki Umeda, Takanori Hosokawa, Ken Ueda, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Yasuhiro Asahina, Shozo Miyake, Nobuyuki Enomoto,